Innovacell Includes First Patients in a Phase IIb Study for Its Cell Therapy Product urocell
16-Jun-2010 -
"First patient in" is the call from the Innsbruck firm, Innovacell Biotechnologie AG, as the first patient was recruited at the MHAT Plovdiv clinic in Bulgaria for the Phase IIb study of the advanced therapy medicinal product, urocell®. The clinical study will be conducted, beside Bulgaria, in ...
Czech Republic
Germany
Poland
+2